The Center Faculty come from all four UCSF Schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

Jeffrey Gotts, MD, PhD

Assistant Professor

Effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.

Jennifer Grandis, MD

Professor, Otolaryngology – Head and Neck Surgery, Associate Vice Chancellor, Clinical and Translational Science Institute

Signal transduction in head and neck squamous cell carcinoma (tobacco-caused cancers) development and progression with the ultimate goal of targeting key pathways for therapeutic benefit.

Lawrence Green, DrPH, MPH

Professor Emeritus
Epidemiology & Biostatistics

Health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies in making practice more evidence-based by making evidence more practice-based.

Joe Guydish, PhD

Institute for Health Policy Studies

Access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings with current focus an organizational change intervention for treatment programs in tobacco dependence.

Sharon Hall, PhD

Professor Emeritus

Clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations.

Carolyn Hendrickson, MD, MPH

Assistant Professor

Effect of smoke on Acute Respiratory Distress Syndrome

Robert A. Hiatt, MD, PhD

Epidemiology & Biostatistics

Cancer epidemiology and studies of cancer etiology, early development, the environment and social determinants.

Lisa Kroon, PharmD

Professor & Chair
Clinical Pharmacy

Tobacco cessation education and training of health professionals.

Susan Lee, MD

Asst Adjunct

Feasibility and acceptability of e-cigarettes versus nicotine replacement therapy for smoking cessation in the perioperative period.

James Lightwood, PhD

Associate Professor
Clinical Pharmacy

Estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws.